Who founded Sidewinder Therapeutics?

Sidewinder Therapeutics was founded by Eric Murphy in 2023.

Who are Sidewinder Therapeutics's investors?

Sidewinder Therapeutics's investors include Astellas Venture Management LLC, DCVC (Data Collective), DCVC Bio, Frazier Life Sciences, Longwood Fund, Novartis Venture Fund, OrbiMed, Frazier Healthcare Partners and 1 more.

Where is Sidewinder Therapeutics headquartered?

Sidewinder Therapeutics is headquartered in San Diego, US.

Sidewinder Therapeutics

San Diego, US · Founded 2023 · 9 employees on LinkedIn · 9 known investors

Find your way into Sidewinder Therapeutics

13 people in our graph can introduce you to the Sidewinder Therapeutics team.

Paths you didn't know you had: your email and LinkedIn already hold routes to the Sidewinder Therapeutics team. We find them
2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sidewinder Therapeutics is a biotechnology company focused on oncology drug discovery and development, working on next-generation cancer treatments.

Biotech Healthtech Medical Devices

Founders & leadership

Sidewinder Therapeutics was founded in 2023 by Eric Murphy.

Eric Murphy Chief Executive Officer, Co-Founder, & DirectorEric Murphy is Chief Executive Officer and co-founder of Sidewinder Therapeutics, a biotechnology company developing oncology treatments. He brings experience in cancer research, drug discovery, pharmacology, and drug development from roles spanning academia, biotech, large pharma, and contract research organizations.

Investors · 9

Astellas Venture Management LLClisted by Astellas Venture Management LLCSouth San Francisco · $200K – $5M

How we know: Astellas Venture Management LLC's portfolio page · Not right? Tell us

DCVC (Data Collective)listed by DCVC (Data Collective)Palo Alto · $5M – $25M

How we know: DCVC (Data Collective)'s portfolio page · open dataset · 5k.vc investor directory · Not right? Tell us

DCVC Biolisted by DCVC BioPalo Alto

How we know: DCVC Bio's portfolio page · a partner's Signal profile · Not right? Tell us

Frazier Life Scienceslisted by Frazier Life SciencesPalo Alto

How we know: Frazier Life Sciences's portfolio page · open dataset · 5k.vc investor directory · Not right? Tell us

Longwood Fundlisted by Longwood FundBoston

How we know: Longwood Fund's portfolio page · open dataset · 5k.vc investor directory · Not right? Tell us

Novartis Venture Fundlisted by Novartis Venture FundBasel · $5M – $25M

How we know: Novartis Venture Fund's portfolio page · open dataset · 5k.vc investor directory · Not right? Tell us

OrbiMedlisted by OrbiMedNew York · $1M – $75M

How we know: OrbiMed's portfolio page · the VCSheet dataset · Not right? Tell us

Frazier Healthcare PartnersreportedSeattle · $50M – $400M

How we know: a partner's Signal profile · Not right? Tell us

Insight PartnersreportedNew York · $120M – $350M

How we know: funding news feeds · Not right? Tell us

Related companies · 3

BioworldBioWorld is a suite of daily news and data services covering therapeutics, medical technology, biopharma business transactions, and drug R&D, serving biopharmaceutical and medtech industry professionals. Owned by Clarivate, it publishes products including BioWorld, BioWorld Science, and BioWorld Asia with reporting from writers stationed globally.

ObsidiantxObsidian Therapeutics develops engineered TIL (tumor-infiltrating lymphocyte) cell therapies for patients with solid tumors, with a lead clinical program (amsoki-cel / OBX-115) treating metastatic melanoma and non-small cell lung cancer. It also licenses its cytoDRiVE platform technology through partnerships to discover novel therapies.

Northwest BiotherapeuticsNW Bio develops personalized dendritic cell-based cancer vaccines intended to treat a range of solid tumor cancers as an alternative to chemotherapy. Its clinical-stage products target cancers including glioblastoma, inoperable solid tumors, ovarian cancer, and prostate cancer.

Companies working in the same space as Sidewinder Therapeutics.

Frequently asked questions

What does Sidewinder Therapeutics do?: Sidewinder Therapeutics is a biotechnology company focused on oncology drug discovery and development, working on next-generation cancer treatments.
Who founded Sidewinder Therapeutics?: Sidewinder Therapeutics was founded by Eric Murphy in 2023.
Who are Sidewinder Therapeutics's investors?: Sidewinder Therapeutics's investors include Astellas Venture Management LLC, DCVC (Data Collective), DCVC Bio, Frazier Life Sciences, Longwood Fund, Novartis Venture Fund, OrbiMed, Frazier Healthcare Partners and 1 more.
Where is Sidewinder Therapeutics headquartered?: Sidewinder Therapeutics is headquartered in San Diego, US.